Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development

Abstract Cytokines and microRNAs (miRNAs) play a crucial function in neurological disorders. The purpose of this study was to investigate the interactions between cytokine networks and miRNA-21, miRNA-155, and miRNA-182 in the cerebrospinal fluid (CSF) of individuals with Parkinson’s disease (PD), A...

Full description

Saved in:
Bibliographic Details
Main Authors: Masoud Nikanfar, Mohammad Nouri, Mehdi Hassanpour, Jafar Rezaei, Alireza Nourazarian
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-05372-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849334770507448320
author Masoud Nikanfar
Mohammad Nouri
Mehdi Hassanpour
Jafar Rezaei
Alireza Nourazarian
author_facet Masoud Nikanfar
Mohammad Nouri
Mehdi Hassanpour
Jafar Rezaei
Alireza Nourazarian
author_sort Masoud Nikanfar
collection DOAJ
description Abstract Cytokines and microRNAs (miRNAs) play a crucial function in neurological disorders. The purpose of this study was to investigate the interactions between cytokine networks and miRNA-21, miRNA-155, and miRNA-182 in the cerebrospinal fluid (CSF) of individuals with Parkinson’s disease (PD), Alzheimer’s disease (AD), and multiple sclerosis. Twenty patients diagnosed with MS, AD, and PD had CSF samples taken, while twenty healthy individuals served as controls. Cytokine levels (IL-6, TNF-α, IL-10, and CCL2) and miRNA expression were determined using an enzyme-linked immunosorbent test (ELISA) and qRT-PCR, respectively. The aim of this study was to identify the correlation between miRNA expression and cytokine levels.Compared with the control group, patients with MS and AD had significantly higher levels of miRNA-21, miRNA-155, and miRNA-182. The disease groups showed increased cytokine levels, particularly in AD and MS. Strong and statistically significant positive correlations were observed between miRNA-21 and IL-6 (r = 0.72, p < 0.001), miRNA-155 and TNF-α (r = 0.68, p < 0.001), and miRNA-182 and CCL2 (r = 0.75, p < 0.001) in all groups. This study provides new insights into the consistent patterns of miRNA expression and cytokine levels in the cerebrospinal fluid of individuals with neurological disorders. The significant correlations between certain miRNAs and cytokines suggest potential regulatory connections, offering valuable information on the pathogenesis of various diseases and identifying potential therapeutic targets.
format Article
id doaj-art-73e42f98c7cb43e0bd56ceab43e838f1
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-73e42f98c7cb43e0bd56ceab43e838f12025-08-20T03:45:28ZengNature PortfolioScientific Reports2045-23222025-07-0115111110.1038/s41598-025-05372-8Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy developmentMasoud Nikanfar0Mohammad Nouri1Mehdi Hassanpour2Jafar Rezaei3Alireza Nourazarian4Department of Neurology, Faculty of Medicine, Tabriz University of Medical SciencesDepartment of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical SciencesDepartment of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical SciencesSolid Tumor Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesAbstract Cytokines and microRNAs (miRNAs) play a crucial function in neurological disorders. The purpose of this study was to investigate the interactions between cytokine networks and miRNA-21, miRNA-155, and miRNA-182 in the cerebrospinal fluid (CSF) of individuals with Parkinson’s disease (PD), Alzheimer’s disease (AD), and multiple sclerosis. Twenty patients diagnosed with MS, AD, and PD had CSF samples taken, while twenty healthy individuals served as controls. Cytokine levels (IL-6, TNF-α, IL-10, and CCL2) and miRNA expression were determined using an enzyme-linked immunosorbent test (ELISA) and qRT-PCR, respectively. The aim of this study was to identify the correlation between miRNA expression and cytokine levels.Compared with the control group, patients with MS and AD had significantly higher levels of miRNA-21, miRNA-155, and miRNA-182. The disease groups showed increased cytokine levels, particularly in AD and MS. Strong and statistically significant positive correlations were observed between miRNA-21 and IL-6 (r = 0.72, p < 0.001), miRNA-155 and TNF-α (r = 0.68, p < 0.001), and miRNA-182 and CCL2 (r = 0.75, p < 0.001) in all groups. This study provides new insights into the consistent patterns of miRNA expression and cytokine levels in the cerebrospinal fluid of individuals with neurological disorders. The significant correlations between certain miRNAs and cytokines suggest potential regulatory connections, offering valuable information on the pathogenesis of various diseases and identifying potential therapeutic targets.https://doi.org/10.1038/s41598-025-05372-8MicroRNACytokinesCerebrospinal fluidMultiple sclerosisAlzheimer’s diseaseParkinson’s disease
spellingShingle Masoud Nikanfar
Mohammad Nouri
Mehdi Hassanpour
Jafar Rezaei
Alireza Nourazarian
Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development
Scientific Reports
MicroRNA
Cytokines
Cerebrospinal fluid
Multiple sclerosis
Alzheimer’s disease
Parkinson’s disease
title Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development
title_full Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development
title_fullStr Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development
title_full_unstemmed Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development
title_short Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development
title_sort elevated mirna 21 mirna 155 and mirna 182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development
topic MicroRNA
Cytokines
Cerebrospinal fluid
Multiple sclerosis
Alzheimer’s disease
Parkinson’s disease
url https://doi.org/10.1038/s41598-025-05372-8
work_keys_str_mv AT masoudnikanfar elevatedmirna21mirna155andmirna182levelscorrelatewithcytokinedysregulationinneurologicaldisordersandindicatepotentialforbiomarkerandtherapydevelopment
AT mohammadnouri elevatedmirna21mirna155andmirna182levelscorrelatewithcytokinedysregulationinneurologicaldisordersandindicatepotentialforbiomarkerandtherapydevelopment
AT mehdihassanpour elevatedmirna21mirna155andmirna182levelscorrelatewithcytokinedysregulationinneurologicaldisordersandindicatepotentialforbiomarkerandtherapydevelopment
AT jafarrezaei elevatedmirna21mirna155andmirna182levelscorrelatewithcytokinedysregulationinneurologicaldisordersandindicatepotentialforbiomarkerandtherapydevelopment
AT alirezanourazarian elevatedmirna21mirna155andmirna182levelscorrelatewithcytokinedysregulationinneurologicaldisordersandindicatepotentialforbiomarkerandtherapydevelopment